V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300006763 | 300004841 | 1.63 | 60.4 | Curative (C) | 2016-09-13 | 2016-10-01 | CETUXIMAB | N | Y | 300022662 | ACTICCA-1 TRIAL |
| 300006764 | 300004841 | 1.6 | null | null | 2016-03-27 | 2016-03-31 | Capecitabine | Y | null | 300022662 | CETUXIMAB |
| 300006765 | 300004842 | null | 75.3 | Neo-adjuvant (N) | 2014-05-04 | 2014-05-09 | Methotrexate intrathecal | N | N | 300022675 | CARBOPLATIN + ETOPOSIDE |
| 300006766 | 300004844 | null | 79.1 | Palliative (P) | 2015-03-29 | 2015-04-11 | Irinotecan + Modified De Gramont | 2 | N | 300022695 | CETUXIMAB + CISPLATIN + FU |
| 300006767 | 300004845 | 1.71 | 53.5 | Palliative (P) | 2017-08-02 | 2017-08-09 | Trial Unspecified | N | N | 300022704 | CAPECITABINE |
| 300006769 | 300004847 | 1.63 | 54.6 | Neo-adjuvant (N) | 2017-07-31 | 2017-07-31 | Gemcitabine + Capecitabine | 2 | N | 300022711 | RITUXIMAB |
| 300006770 | 300004848 | 1.51 | 58 | Palliative (P) | 2016-03-03 | 2016-03-22 | Bevacizumab 5mg/kg | N | N | 300022711 | CARBOPLATIN + PACLITAXEL |
| 300006771 | 300004851 | 1.73 | 115 | Not known (9) | null | 2017-08-31 | Oxaliplatin + Modified de Gramont | null | null | 300022737 | CARBOPLATIN + RT |
| 300006773 | 300004856 | 1.56 | 67.3 | Palliative (P) | 2014-08-15 | 2014-08-27 | Carboplatin + Cetux + FU (Cycle 1) | N | N | 300022796 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300006774 | 300004857 | 1.76 | null | Disease modification (D) | 2018-03-07 | 2018-03-18 | Hydroxycarbamide | N | N | 300022815 | CISPLATIN |
| 300006775 | 300004858 | 1.6 | 59.9 | Palliative (P) | 2013-04-30 | 2013-05-16 | Bevacizumab 7.5mg/kg | N | N | 300022846 | CARBOPLATIN + ETOPOSIDE |
| 300006778 | 300008136 | 1.64 | 101 | Curative (C) | 2016-11-18 | 2016-11-24 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 300022912 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300006779 | 300004863 | 1.6 | 110 | Curative (C) | 2016-08-24 | 2016-09-04 | CARBOPLATIN + RT | N | Y | 300022938 | CETUXIMAB + RT |
| 300006780 | 300004863 | 1.65 | 59.2 | null | null | 2016-08-12 | Oxaliplatin + Modified de Gramont | 2 | null | 300022938 | MITOMYCIN |
| 300006781 | 300004865 | 1.74 | 63 | Curative (C) | 2017-04-29 | 2017-05-02 | Cetuximab +Cisplatin + FU (Cycle 1) | 2 | Y | 300022967 | CETUXIMAB + RT |
| 300006782 | 300004869 | 1.56 | 65 | Curative (C) | 2017-12-13 | 2018-01-16 | Cisplatin | null | Y | 300022977 | CARBOPLATIN |
| 300006783 | 300004870 | 1.66 | 75.5 | Not known (9) | 2014-10-09 | 2014-10-17 | TOTEM TRIAL | 1 | N | 300022992 | CAV |
| 300006784 | 300004870 | 1.64 | 63.4 | Palliative (P) | 2016-07-14 | 2016-07-23 | CARBOPLATIN + PACLITAXEL | N | N | 300022992 | OXALIPLATIN + MDG |
| 300006785 | 300007019 | 0 | null | Curative (C) | 2017-08-05 | 2017-08-06 | Cetuximab + Radiotherapy Maint | N | Y | 300023002 | CARBOPLATIN + RT |
| 300006786 | 300007019 | 1.49 | 75.3 | Not known (9) | 2018-03-09 | 2018-03-14 | Capecitabine 42days + RT | N | Y | 300023002 | CISPLATIN + FLUOROURACIL + RT |
| 300006787 | 300004873 | 1.63 | 90.7 | Curative (C) | 2016-06-06 | 2016-08-13 | Lomustine | N | N | 300023062 | IRINOTECAN + MDG |
| 300006788 | 300004873 | 1.81 | 81.8 | Neo-adjuvant (N) | null | 2016-10-17 | Carboplatin AUC 6 - 10 | null | null | 300023062 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300006789 | 300004874 | null | 77.2 | Neo-adjuvant (N) | 2013-12-27 | 2014-01-01 | Capecitabine | Y | N | 300023085 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300006790 | 300007021 | 1.59 | 62.8 | Palliative (P) | null | 2017-12-29 | CAV | N | null | 300023085 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300006791 | 300004875 | 1.6 | 20.2 | Neo-adjuvant (N) | 2014-10-17 | 2014-10-24 | Docetaxel | N | N | 300023107 | SUNITINIB |
| 300006792 | 300004875 | 1.72 | 134 | Curative (C) | 2017-05-26 | 2018-03-10 | Cisplatin 7 day | 2 | Y | 300023107 | CISPLATIN |
| 300006793 | 300004875 | 1.74 | null | Neo-adjuvant (N) | 2014-10-03 | 2014-10-17 | CAPECITABINE + CARBOPLATIN + Cetuximab | N | N | 300023107 | EOX |
| 300006794 | 300008139 | 1.52 | 40 | Palliative (P) | 2014-09-27 | 2015-02-28 | Cetuximab +Cisplatin + FU (Cycle 1) | 02 | N | 300023134 | IMATINIB |
| 300006795 | 300008139 | 1.7 | 54 | Neo-adjuvant (N) | 2015-07-06 | 2015-07-09 | DE-ESCALATE TRIAL | N | null | 300023134 | CARBOPLATIN |
| 300006796 | 300004876 | null | 70.6 | Palliative (P) | 2015-01-06 | 2015-01-06 | Oxaliplatin + Modified de Gramont | N | N | 300023175 | CARBOPLATIN + CETUXIMAB + FU |
| 300006797 | 300004878 | null | null | Neo-adjuvant (N) | null | 2013-10-17 | Carboplatin AUC 6 - 10 | null | null | 300023186 | ESPAC TRIAL |
| 300006798 | 300007023 | 1.71 | 61.9 | Curative (C) | 2015-01-14 | 2015-01-14 | Oxaliplatin + Modified de Gramont | 02 | N | 300023187 | CISPLATIN + FLUOROURACIL |
| 300006799 | 300004881 | 1.69 | null | null | 2013-04-14 | 2013-04-21 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | N | Y | 300023188 | CISPLATIN + FLUOROURACIL |
| 300006800 | 300004882 | 1.71 | null | null | 2016-03-28 | 2016-04-18 | Capecitabine | N | null | 300023188 | CARBOPLATIN + DOCETAXEL |
| 300006801 | 300004883 | 1.85 | 52 | Neo-adjuvant (N) | 2017-01-04 | 2017-01-09 | Trial Unspecified | N | N | 300023226 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 300006802 | 300004884 | 1.6 | 62.4 | Adjuvant (A) | 2015-05-25 | 2015-06-15 | Cisplatin | null | Y | 300023243 | CARBOPLATIN + PACLITAXEL |
| 300006803 | 300004886 | null | 57 | Neo-adjuvant (N) | 2014-10-30 | 2014-10-30 | Capecitabine + Oxaliplatin 21day | N | N | 300023270 | NIVOLUMAB |
| 300006804 | 300004889 | 1.72 | null | Palliative (P) | 2014-12-08 | 2014-12-19 | Irinotecan + Modified De Gramont | N | N | 300023292 | CYCLOPHOSPHAMIDE |
| 300006809 | 300008278 | 1.65 | null | Curative (C) | 2014-08-17 | 2014-08-28 | Cetuximab 7 day (>Cycle 2) | N | Y | 300023344 | NOT MATCHED |
| 300006811 | 300004892 | null | 62.2 | Neo-adjuvant (N) | 2014-11-28 | 2014-12-23 | Cisplatin | N | null | 300023390 | IVA |
| 300006812 | 300004894 | null | 67.9 | Palliative (P) | 2014-09-05 | 2014-09-06 | Cisplatin 7 day | 02 | null | 300023404 | CAPECITABINE |
| 300006813 | 300004895 | null | 100.4 | null | 2016-04-18 | 2016-05-06 | Epirubicin intravesical | Y | null | 300023414 | CISPLATIN + FLUOROURACIL |
| 300006814 | 300004896 | null | 73.5 | Curative (C) | 2016-10-23 | 2017-01-27 | CISPLATIN + FLUOROURACIL | 02 | N | 300023427 | CARBOPLATIN + PACLITAXEL |
| 300006815 | 300007029 | 1.76 | null | Adjuvant (A) | 2015-03-24 | 2015-04-14 | PACLITAXEL | N | null | 300023449 | CETUXIMAB |
| 300006816 | 300004898 | 1.72 | 83 | Palliative (P) | 2016-09-12 | 2016-10-03 | GemCarbo Days 1+8 | Y | N | 300023466 | IRINOTECAN + MDG |
| 300006817 | 300004898 | 1.79 | 98.3 | Adjuvant (A) | 2017-12-05 | 2017-12-05 | Nilotinib | 2 | N | 300023466 | TRIAL |
| 300006818 | 300004900 | 1.67 | null | Curative (C) | 2013-07-05 | 2013-07-05 | CETUXIMAB | 2 | null | 300023471 | CARBOPLATIN |
| 300006819 | 300004900 | null | 72.4 | Palliative (P) | null | 2017-07-26 | GEMCITABINE + NAB PACLITAXEL | N | N | 300023471 | OXALIPLATIN + MDG |
| 300006820 | 300004903 | 1.67 | 58.9 | Curative (C) | 2013-07-24 | 2013-09-18 | NIVOLUMAB | N | N | 300023483 | CAPECITABINE + GEMCITABINE |
| 300006821 | 300004904 | 1.74 | 54.8 | Palliative (P) | 2012-05-26 | 2012-06-27 | Capecitabine | N | N | 300023503 | CAPECITABINE + OXALIPLATIN |